All Times PACIFIC. Program Subject to Change
FRIDAY, March 13, 2026
11:00am-12:00pm
Registration, Coffee, Visit Exhibits
12:00-1:00pm
Product Theatre Luncheon - Non-CME Title TBD
1:00-1:15pm
Coffee Break and Visit Exhibits
SESSION I
1:15-1:25pm
Introduction to the 30th Annual Symposium: Heart Failure 2026 – An Update on Therapy Uri Elkayam, MD, FACC
1:25-1:45pm
Recommendations for the Management of Heart Failure in Patients with Chronic Kidney Disease Maria Rosa Costanzo, MD
1:45-2:05pm
Balancing GDMT and Hyperkalemia Ileana L. Piña, MD
2:05-2:25pm
Digitoxin in Heart Failure: A Comeback for Digitalis? Tien Ng, PharmD
2:25-2:45pm
Introducing Finerenone: A New Drug for the Management of Heart Failure and Chronic Kidney Disease Akshay Desai, MD
2:45-3:05pm
Vericiguat in Heart Failure: When and How to Use It Barry Greenberg, MD
3:05-3:25pm
The Contemporary Management of HFpEF Akshay Desai, MD
3:25-3:40pm
SESSION II
3:40-4:00pm
Our Journey with Diuretics: 240 Years, and How Far Have We Come? Marvin Konstam, MD
4:00-4:20pm
Treating Congestion in Patients with Acute Decompensated Heart Failure: Where Are We Now? Where Are We Going? William Abraham, MD
4:20-4:40pm
Releasing the Brakes on the Immune System in Cancer: Implications in Myocarditis and Beyond Eric Yang, MD
4:40-5:00pm
Clinical Experience with the Use of Myosin Inhibitors in the Treatment of Obstructive and Non-Obstructive Hypertrophic Cardiomyopathy Jessica Wang, MD
5:00-5:20pm
Contemporary Management of Obesity in Patients with Heart Failure Norman Lepor, MD
5:20pm
Adjourn
SATURDAY, March 14, 2026
7:00am
Registration Open
7:15-7:45am
Case Discussion Uri Elkayam, MD; Maria Rosa Costanzo, MD; Barry Greenberg, MD
7:45-8:45am
Product Theatre Breakfast - Non-CME Title TBD
8:45-9:00am
Break and Visit the Exhibits
SESSION III
9:00-9:15am
Introduction to Day Two: 30th Annual Symposium: Heart Failure 2026 - An Update on Therapy Uri Elkayam, MD
9:15-9:35am
GDMT for Chronic HFrEF: How to Maximize the Benefits? Gregg Fonarow, MD
9:35-9:55am
Cardiogenic Shock: Hemodynamic Classification and Management Rola Khedraki, MD
9:55-10:15am
Percutaneous Coronary Interventions in Ischemic Cardiomyopathy – Does It Work? Christina Economides, MD
10:15-10:35am
Bio-Omics in Heart Failure Diagnosis and Therapy Kirkwood Adams, MD
10:35-10:55am
SESSION IV
10:55-11:15am
Genetic Testing for Cardiomyopathy Josh Hare, MD
11:15-11:35am
Gene Therapy for Patients with Cardiomyopathy Barry Greenberg, MD
11:35-11:55am
Stem Cell Therapy for the Management of Myocardial Disease: A Status Report Josh Hare, MD
11:55-12:15pm
Clinical Characteristics and Management of Methamphetamine-Associated Cardiomyopathy Uri Elkayam, MD
12:15-12:35pm
Update on the Management of Atrial Fibrillation in Patients with Heart Failure Anil Bhandari, MD
12:35-1:35pm
Product Theatre Luncheon - Non-CME Title TBD
1:35-1:50pm
SESSION V
1:50-2:20pm
KEYNOTE LECTURE 30 Years of Innovation in the Management of Heart Failure: A Perspective Clyde Yancy, MD
2:20-2:40pm
Bromocriptine in the Management of Peripartum Cardiomyopathy: Pathophysiologic Mechanism and Available Data Uri Elkayam, MD
2:40-3:00pm
What Is New in Myocarditis: An Update from the ESC 2025 Guidelines Leslie Cooper, MD
3:00-3:20pm
Pulmonary Hypertension: New Drugs and How to Use Them Thomas Heywood, MD
3:20-3:40pm
Innovations in Device Therapy for Heart Failure William Abraham, MD
Break and Visit Exhibits
SESSION VI
The Use of AI in the Management of Heart Failure Nir Uriel, MD
Autonomic Modulation in Heart Failure Treatment: Where Are We and Where Are We Heading? Marvin Konstam, MD
LVAD vs Heart Transplantation: A Perspective Nir Uriel, MD
Individual Selection of Drug Therapy in Patients with Transthyretin (TTR) Amyloidosis Mazen Hanna, MD